Covered recipient · General Payments record
STACEY DENISE DINES
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$728.08
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $336.86 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $78.78 | 4 |
| Novo Nordisk AS | $59.40 | 3 |
| Medtronic, Inc. | $51.42 | 1 |
| Ardelyx, Inc. | $38.01 | 2 |
| Exact Sciences Corporation | $29.80 | 1 |
| DEXCOM, INC. | $19.51 | 1 |
| Amgen Inc. | $16.13 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.27 | 1 |
| Acerta Pharma LLC | $14.85 | 1 |
| PFIZER INC. | $13.69 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $16.13 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117542282 | CMS |
| Ardelyx, Inc. | $19.38 | 05/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146724534 | CMS |
| Ardelyx, Inc. | $18.63 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146724536 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.85 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105665878 | CMS |
| Dexcom, Inc. | $19.51 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153387380 | CMS |
| Exact Sciences Corporation | $29.80 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114445228 | CMS |
| Lilly USA, LLC | $18.91 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135951110 | CMS |
| Lilly USA, LLC | $17.03 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135965552 | CMS |
| Lilly USA, LLC | $23.08 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135965554 | CMS |
| Lilly USA, LLC | $19.76 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135951112 | CMS |
| Medtronic, Inc. | $51.42 | 04/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116967698 | CMS |
| Novo Nordisk Inc | $18.03 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100625602 | CMS |
| Novo Nordisk Inc | $19.24 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100655961 | CMS |
| Novo Nordisk Inc | $22.13 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100559455 | CMS |
| PFIZER INC. | $13.69 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130887749 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $15.27 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153500703 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.